Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation

Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug

(2016) Gennaro Santoro et al.   EuroIntervention

Two-year clinical outcome from the Iberian registry patients after left atrial appendage closure

(2015) José Ramón López Mínguez et al.   HEART

Periprocedural Intracardiac Echocardiography for Left Atrial Appendage Closure

(2014) Sergio Berti et al.   JACC-Cardiovascular Interventions

Amplatzer left atrial appendage occlusion: Single center 10-year experience

(2013) Fabian Nietlispach et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation Therapy

(2013) Marina Urena et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Left Atrial Appendage Closure With the Watchman Device in Patients With a Contraindication for Oral Anticoagulation

(2013) Vivek Y. Reddy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Tools and Techniques Clinical: Transcatheter closure of left atrial appendage using the Amplatzer™ Cardiac Plug

(2013) Sergio Berti et al.   EuroIntervention

Oclusão do apêndice atrial esquerdo com o Amplatzer Cardiac Plug em pacientes com fibrilação atrial

(2012) Ênio Eduardo Guérios et al.   Arquivos Brasileiros de Cardiologia

Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

(2012) Leif Friberg et al.   EUROPEAN HEART JOURNAL

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Resultados inmediatos y a más de un año en 35 pacientes consecutivos a los que se realiza cierre de orejuela izquierda con el dispositivo Amplatzer Cardiac Plug

(2012) José R. López-Mínguez et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study

(2010) Yves-Laurent Bayard et al.   EuroIntervention

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy

(2009) Peter C. Block et al.   JACC-Cardiovascular Interventions

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

(2009) David R Holmes et al.   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE